Medizinische Fakultät

Phase-sensitive individualized pharmacotherapy for alcohol use disorder (2026) Müller CP, Lenz B, Kornhuber J, Ebner-Priemer UW, Schwarz E, Ersche KD, Kiefer F, Spanagel R Journal article, Review article Surgical predictors of osteoradionecrosis in irradiated head and neck cancer patients: Jaw resection increases risk whereas neck dissection does not (2026) Hirsch J, Krause I, Tangmanee C, Vorwerk H, Stuck B, Poramate PA, Neff A Journal article Analyzing and adapting diffusion segmentation behavior for medical images (2026) Öttl M, Mei S, Wilm F, Qiu J, Steenpaß J, Rübner M, Hartmann A, et al. Journal article Using smart devices for prenatal care: Assessing the willingness among women with pregnancy-related anxiety (2026) Altmannshofer S, Weidenthaler F, Titzmann A, Pontones C, Danzberger N, Jäger K, Nissen M, et al. Journal article, Original article Effects of a complex intervention on agitation and aggression in people living with dementia and mild cognitive impairment in shared-housing arrangements: results for a secondary outcome of the multicenter, cluster-randomized controlled DemWG study (2026) Donath C, Kratzer A, Grässel E, Keck A, Günay S, Altona J, Misonow J, et al. Journal article A comparative evaluation of parafoveal and perifoveal macular vessel density loss in glaucoma using 3 × 3 mm OCTA scans (2026) Garcia Kahmeyer D, Mardin C, Lämmer R, Hohberger B, Schottenhamml J Journal article Genetic basis of chronic nonbacterial osteomyelitis Genetischer Hintergrund der chronischen nichtbakteriellen Osteomyelitis (2026) Hayatu MD, Hüffmeier U Journal article Long-range chemical signalling in vivo is regulated by mechanical signals (2026) Pillai EK, Mukherjee S, Gampl N, McGinn R, Mooslehner K, Becker J, Winkel AK, et al. Journal article NK cell-mediated tumor cell killing by bispecific innate cell engagers induces ADCC-mediated activation of primary human dendritic cells (2026) Heger L, Kaszubowski T, Amon L, Lehmann C, Wingert S, Medina-Echeverz J, Koch J, et al. Journal article Characteristics and quality of life of nine-year survivors with metastatic melanoma treated with pembrolizumab beyond second-line therapy (2026) Dugas-Breit S, Forschner A, Erdmann M, Gutzmer R, Kähler KC, Holst I, Brekner A, et al. Journal article